Rufang Xiang

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia

Jun Long, Mingyuan Jia, Weiyue Fang et al. · Blood · 2020 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +13

Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy

Jia Tong, Xiaoguang Xu, Zilu Zhang et al. · Haematologica · 2019 · 66 citations · Full text

Medicine, Molecular Biology, Oncology +15

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway

Rufang Xiang, Yan Wang, Nan Zhang et al. · Cell Death and Disease · 2017 · 52 citations · Full text

Medicine, Oncology, Pharmacology +16

Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition

Bo Jing, Jin Jin, Rufang Xiang et al. · Cell Death and Disease · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance

Wenjun Yu, Yubao Chen, Rufang Xiang et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 23 citations

Medicine, Oncology, Pharmacology +17